NEUE EGFR-INHIBITOREN
European patent · EP3986566 · In force
Register entry
- Publication number
- EP3986566
- Application number
- EP20734487
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 19, 2020
- Published
- Apr 27, 2022
- Granted
- Aug 30, 2023
- Protection ends at the latest
- Jun 18, 2040
- Next annual fee due
- Jun 30, 2026
- IPC classes
- A61P 35/00 (2006.01)C07D 417/14 (2006.01)A61K 31/427 (2006.01)
- Priority
- EP 19181772 21.06.2019
- PCT application
- PCT/EP2020/067055 19.06.2020
- PCT publication
- WO2020/254546 24.12.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2025
Change
Published in Swissreg on 01.07.2025
- Jul 10, 2024
Change
Published in Swissreg on 10.07.2024
- Jul 1, 2024
Change
Published in Swissreg on 01.07.2024
- Aug 30, 2023
Granted
Published in Swissreg on 30.08.2023
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.